Cargando…
Platelet-Derived Growth Factors: A New Therapeutic Opportunity for Treating Cardiac Fibrosis?
[Figure: see text]
Autor principal: | Mouton, Alan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322860/ https://www.ncbi.nlm.nih.gov/pubmed/37426528 http://dx.doi.org/10.1016/j.jacbts.2023.01.014 |
Ejemplares similares
-
Cardiac Myosin Protein C: New Roles, New Questions, Potential Opportunities
por: Blanton, Robert M., et al.
Publicado: (2017) -
ECMO in children post cardiac surgery-opportunity for redress
por: Alwi, Mazeni
Publicado: (2017) -
TGF-β Inhibitor CILP as a Novel Biomarker for Cardiac Fibrosis
por: Groß, Sonja, et al.
Publicado: (2020) -
Putting the Heat on Cardiac Fibrosis: Hsp20 Regulates Myocyte-To-Fibroblast Crosstalk
por: Major, Jennifer L., et al.
Publicado: (2019) -
Connecting the Dots for Connective Tissue Growth Factor Roles in Cardiac Wound Healing After Myocardial Infarction
por: Hale, Taben M., et al.
Publicado: (2019)